Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « MeshFr.i » - entrée « Azithromycine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Avortement spontané < Azithromycine < Aéroports  Facettes :

List of bibliographic references indexed by Azithromycine

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000010 (2020) Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis]Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
000011 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000016 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
000047 (2020) Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique]Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
000051 (2020) Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France]Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
000053 (2020) David Lebeaux [France] ; Matthieu Revest [France]No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
000065 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000467 (2020) François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France]The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
000513 (2020) Achille Aouba [Oman] ; Aurelie Baldolli [France] ; Loïk Geffray [France] ; Renaud Verdon [France] ; Emmanuel Bergot [France] ; Nicolas Martin-Silva [France] ; Aurélien Justet [France]Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
000535 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000536 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000745 (2020) Christian Funck-Brentano [France] ; Joe-Elie Salem [France] ; Lee S. Nguyen [France] ; Milou-Daniel Drici [France] ; Dan M. Roden [États-Unis]Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
000776 (2020) Alan G. Fraser [Royaume-Uni, Belgique] ; Piotr Szyma Ski [Pologne] ; Elizabeth Macintyre [France] ; Martin Landray [Royaume-Uni]Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?
000A53 (2020) J M Molina [France] ; C. Delaugerre [France] ; J. Le Goff [France] ; B. Mela-Lima [France] ; D. Ponscarme [France] ; L. Goldwirt [France] ; N. De Castro [France]No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
000C03 (2020) Matthias Jacquet-Lagrèze [France] ; Zakaria Riad [France] ; Elisabeth Hugon-Vallet [France] ; Arnaud Ferraris [France] ; Jean-Luc Fellahi [France]Left ventricular dysfunction in COVID-19: A diagnostic issue.
000C48 (2020) J M Scherrmann [France]Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.
000C99 (2020) Julien Andreani [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Priscilla Jardot [France] ; Clara Rolland [France] ; Manon Boxberger [France] ; Nathalie Wurtz [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Didier Raoult [France]In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect.
000D92 (2020) Ibrahim Yakoub-Agha [France]Hydroxychloroquine in Covid-19: Does the end justify the means?
000D96 (2020) Philippe Giaime [France] ; Maxime Guenoun [France] ; Nathalie Pedinielli [France] ; Hervé Narbonne [France] ; Jean-Philippe Bergounioux [France] ; Caroline Solas [France] ; Romain Guilhaumou [France] ; Jérôme Sampol [France] ; Jacques Ollier [France] ; Hélène Sichez [France] ; Marianne Serveaux [France] ; Flora Brunner [France] ; Stanislas Bataille [France]Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
000D97 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Johan Courjon [France] ; Valérie Giordanengo [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Dupont [France] ; Stéphane Honoré [France] ; Philippe Colson [France] ; Eric Chabrière [France] ; Bernard La Scola [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
000D98 (2020) Alice Fanin [Italie] ; Jessica Calegari [Italie] ; Anna Beverina [Italie] ; Silvia Tiraboschi [Italie]Hydroxychloroquine and azithromycin as a treatment of COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Azithromycine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Azithromycine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Azithromycine
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021